Infectious diseases: full human system mouse models for HIV, Dengue, CMV and corona virus.

The Do’s and Don’ts by the TransCure bioServices Experts.

June 25th, 2020

Sebastien Tabruyn, PhD Chief Scientific Officer (CSOHosted online by
Sebastien Tabruyn, PhD, CSO
for a 45 minutes presentation.

Download the presentation and watch the full replay:

  • Ask for your full access via the form 

You will learn:

  • What are the main characteristics of a predictive HIV mouse model regarding efficacy, resistance, rebound and latency?
  • How comparable to human HIV disease progression is the HIV-hu-mouse model?
  • Why is the HIV-hu-mouse model developed by TransCure bioServices superior to SIV monkey disease model?
  • Several case studies will be presented in detail: Prophylactic treatment, HAART treatment and rebound, Anti-viral drug, vaccination.
  • We will discuss human CMV, dengue and corona virus models as well.

Who is Sebastien Tabruyn?

Sebastien Tabruyn, PhD Chief Scientific Officer (CSO). He holds a PhD in Molecular Biology from the University of Liege (Belgium). After 15 years of experience as Project leader in renowned international academic research institutes including UCSF (California, USA), the Centre for Cancer Biology (Adelaide, Australia) and the University of Maastricht (Netherlands), he joined TransCure bioServices in 2013 as Head of Molecular Biology and Oncology. Sebastien Tabruyn published 35 peer-reviewed publications in the field of Oncology, Angiogenesis, Inflammation and Immunity.

Instant webinar access

Our latest news

New Disease Model: human hepatocytes (hu-liver) Mouse Models

TransCure bioServices launches its human hepatocytes (hu-liver) mouse models! Innovative preclinical model thanks to TransCure bioServices ! Our initial human hepatocyte liver disease model (hu-PIRF) has now been fully validated in house thanks to our collaboration...

Brand New Rodent Animal Facility at TransCure bioServices

State-of-the-Art and Expanded Animal Facilities at TransCure bioServices We have totally refurbished and remodeled our extended animal facility (now more than 500 m2 – upgraded 300 m2 last year) with automatic sliding doors, several dedicated rooms for...

Webinar 2021 Sessions in Immuno-Oncology, IBD and Infectious Diseases

Webinar 2020 Series: Immuno-Oncology, IBD, and Infectious Diseases are available here. In mid-2020, our CSO Dr. Sebastien Tabruyn, PhD hosted our first webinar-series focusing on our core expertise: immuno-oncology, inflammation and infectious disease using full human...

TransCure bioServices Latest Arrivals

Official introduction of our last two hires at TransCure bioServices! TransCure bioService is welcoming two new employees in its growing team! See below: Lucie Pinteau holds a professional license/degree in biotechnology from UPMC (Paris) after having validated a DUT...

Our profession:
in vivo pharmacology services

Please feel free to contact us


Share this!